Remedium Lifecare Limited (BOM:539561)

Total Valuation

BOM:539561 has a market cap or net worth of INR 624.96 million. The enterprise value is 12.02 billion.

Market Cap	624.96M
Enterprise Value	12.02B

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BOM:539561 has 403.20 million shares outstanding. The number of shares has increased by 37.42% in one year.

Current Share Class	403.20M
Shares Outstanding	403.20M
Shares Change (YoY)	+37.42%
Shares Change (QoQ)	+127.21%
Owned by Insiders (%)	60.85%
Owned by Institutions (%)	7.57%
Float	85.62M

Valuation Ratios

The trailing PE ratio is 16.76.

PE Ratio	16.76
Forward PE	n/a
PS Ratio	0.14
PB Ratio	1.42
P/TBV Ratio	1.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	233.84
EV / Sales	2.73
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	26.01
Debt / EBITDA	2,861.35
Debt / FCF	n/a
Interest Coverage	0.07

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	0.04%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	629.89M
Profits Per Employee	7.35M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BOM:539561 has paid 26.88 million in taxes.

Income Tax	26.88M
Effective Tax Rate	34.33%

Stock Price Statistics

The stock price has decreased by -77.49% in the last 52 weeks. The beta is 1.13, so BOM:539561's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	-77.49%
50-Day Moving Average	1.43
200-Day Moving Average	2.19
Relative Strength Index (RSI)	62.93
Average Volume (20 Days)	9,904,035

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:539561 had revenue of INR 4.41 billion and earned 51.42 million in profits. Earnings per share was 0.09.

Revenue	4.41B
Gross Profit	110.33M
Operating Income	3.65M
Pretax Income	78.30M
Net Income	51.42M
EBITDA	3.99M
EBIT	3.65M
Earnings Per Share (EPS)	0.09

Balance Sheet

The company has 14.27 million in cash and 11.41 billion in debt, giving a net cash position of -11.40 billion or -28.27 per share.

Cash & Cash Equivalents	14.27M
Total Debt	11.41B
Net Cash	-11.40B
Net Cash Per Share	-28.27
Equity (Book Value)	438.91M
Book Value Per Share	1.07
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 2.50%, with operating and profit margins of 0.08% and 1.17%.

Gross Margin	2.50%
Operating Margin	0.08%
Pretax Margin	1.78%
Profit Margin	1.17%
EBITDA Margin	0.09%
EBIT Margin	0.08%
FCF Margin	n/a

Dividends & Yields

BOM:539561 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.42%
Shareholder Yield	-37.42%
Earnings Yield	8.23%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 5, 2024. It was a forward split with a ratio of 4.

Last Split Date	Jul 5, 2024
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	2